EU Blueprint survey: exploitation terms are becoming proposal strategy

On 17 July 2026, the European Commission's Directorate-General for Research and Innovation announced a survey on the upcoming EU Blueprint for intellectual property licensing and spinoff creation. The survey is linked to the Commission's EU Startup and Scaleup Strategy and its Lab to Unicorn initiative. The Commission says the Blueprint is intended to help universities and public research organisations commercialise publicly funded research results through practical guidance on areas including licensing academic intellectual property to third parties, royalty and revenue sharing, equity participation in academic spin-offs and incentives for researchers. Stakeholders are invited to respond online until 16 August 2026, and the Blueprint is expected to be finalised by the end of 2026.

This is a material Horizon Europe ecosystem development, but it should be described accurately. It is not a new Horizon Europe call. It does not create a call status, funding instrument, topic budget, applicant eligibility route, geography rule, grant deadline or submission form. It is a consultation on future guidance. Its importance is that it touches one of the recurring weak points in research and innovation proposals: the gap between promised impact and the real institutional terms needed to move knowledge into use.

For proposal teams, the central lesson is that exploitation cannot remain a late annex or a generic work package. Horizon Europe proposals often describe publications, intellectual property protection, market studies, policy engagement, pilots, standardisation or spin-off intentions, but leave the harder decisions unresolved. Who owns background knowledge? Who will own foreground results? Which partner has the right to license which asset? How will revenue or equity be handled if a university spin-off is formed? What incentives make researchers and public institutions willing to commercialise results rather than merely report them? These questions affect the credibility of impact, the allocation of tasks, the budget and the consortium agreement.

The Commission's Startup and Scaleup Strategy page frames this agenda as part of a wider competitiveness effort. It identifies actions across regulation, financing, market uptake, talent and infrastructure, and records that the Scaleup Europe Fund is expected to become operational in autumn 2026 after legal agreements and investor commitments are finalised. The same strategy page lists the IP licensing and spinoff survey as a live latest item. The policy direction is therefore consistent: Europe wants more publicly funded research to become investable companies, usable products, public value and jobs. A Horizon Europe consortium that promises commercialisation should expect reviewers, partners and investors to look beyond attractive language and ask whether the institutional route is credible.

Universities and public research organisations should use the consultation period as an internal readiness check. A research office, technology-transfer office or principal investigator does not need to wait for the final Blueprint before improving proposal discipline. They can map standard positions on background IP, foreground ownership, publication clearance, patenting responsibilities, option rights, licensing decision authority, royalty sharing, equity participation, founder involvement and conflict-of-interest management. Where policy is unclear, the proposal should not pretend that the issue is solved. It should identify the decision point, owner and route to resolution.

SMEs, founders and investors should read the development through a transaction lens. A promising Horizon result may still fail to scale if the venture cannot secure clean rights, predictable licensing terms, access to key data, founder participation or investor-acceptable governance. When a proposal relies on a future spin-off or licensing route, the exploitation plan should explain what asset is expected, who needs it, what proof is required, what commercial route is plausible and which legal or institutional constraints must be resolved during the project. This does not mean promising a specific investment outcome. It means making the assumptions visible enough to test.

African and Ugandan organisations should be especially careful in consortia where commercialisation language is prominent. International partners may contribute implementation contexts, datasets, stakeholder access, market knowledge, training capacity, validation sites, local adaptation insight or policy pathways. Those contributions can be strategically valuable, but they also create questions about data rights, knowledge ownership, benefit sharing, publication, exploitation access and post-project use. A partner should not accept a decorative role in a proposal that later turns its contribution into value elsewhere without clear terms. The right time to clarify these points is before submission, not when the consortium agreement becomes urgent.

For coordinators, PRINCEPS recommends adding an exploitation-terms gate before the full draft is locked. The gate should answer: which results may have commercial or policy value; which partners bring protected background; what new foreground is expected; who will decide on protection, publication and licensing; what spin-off or third-party licensing route is plausible; how are researchers incentivised; what happens for non-European implementation partners; and where are these points reflected in the work plan, risk register, budget and consortium-agreement timetable? If the proposal cannot answer these questions at a reasonable level, the impact section is not yet evaluator-ready.

The practical action is immediate. Universities, public research organisations, technology-transfer professionals, researchers, founders, innovative companies, investors and public authorities that have evidence to contribute should review the Commission survey and discussion paper before 16 August 2026. Proposal teams should separately update their own exploitation templates, partner due-diligence questions and consortium-agreement timetable. This analysis is editorial and strategic. It is not legal, tax, investment, intellectual-property, procurement or grant-award advice, and it does not guarantee funding, market access or spin-off success. Teams should verify the live Commission survey, the EU Startup and Scaleup Strategy materials, Funding & Tenders Portal topic documents and qualified professional advice before acting.

Editorial note: This is PRINCEPS analysis for general information. It does not replace the official work programme, topic conditions, submission system, grant rules or professional advice specific to an application.